In addition, the study from Thorsson et al[28] distinguished C1 to C6, 6 immune subtypes for ovarian cancer, TISIDB database showed CX3XR1 expressed in C1 (wound healing type), C2 (IFN-γ dominant type), C3 (inflammatory type) and C4 (lymphocyte depleted type) subtypes, and highest expressed in C3 (inflammatory) type of epithelial ovarian cancer (Fig. 3F). This evidence concerns the gene IFNG and ovarian carcinoma.